<DOC>
	<DOCNO>NCT00774020</DOCNO>
	<brief_summary>The purpose study document efficacy safety profile single intravenous dose 5 mg zoledronic acid Chinese patient Paget 's Disease Bone ( PDB ) .</brief_summary>
	<brief_title>Efficacy Safety Single Dose 5 mg Zoledronic Acid Chinese Patients With Paget 's Disease Bone ( PDB )</brief_title>
	<detailed_description />
	<mesh_term>Bone Diseases</mesh_term>
	<mesh_term>Osteitis Deformans</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Confirmed diagnosis PDB radiological report Serum Alkaline Phosphatase level ( SAP ) least two time upper limit normal ( ULN ) History hypersensitivity active substance excipients bisphosphonates ; History malignancy organ system Severe liver bladder disease ; Calculated creatinine clearance &lt; 35 mL/min baseline ; Hypocalcaemia ; Patients preexist dental disease predict dental surgery study ; Evidence vitamin D deficiency . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Paget 's Disease Bone</keyword>
	<keyword>Serum Alkaline Phosphatase</keyword>
</DOC>